During the past decade, Central Cardiology Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Central Cardiology Associates" are "Cardiovascular Disease" (2 trials), "Angina Pectoris" (1 trials), "Atrial Fibrillation" (1 trials), "Coronary Artery Disease" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Central Cardiology Associates" in a lesser frequency.

Most popular intervention types in "Central Cardiology Associates" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Ranolazine" (1 trials) and "Ranolazine placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Cardiology Associates" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Central Cardiology Associates". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Central Cardiology Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Central Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".